Christopher J. Regan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christopher J. Regan has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Mena-Hurtado
Yale School of Medicine
1 shared publication - Leila Haghighat
Division of Cardiology, Department of Medicine, University of California-San Francisco , San Francisco, 500 Parnassus Avenue, Box 1354, CA 94143-1354
1 shared publication - Robert R. Attaran
Yale Heart and Vascular Center, Yale School of Medicine, New Haven, Connecticut
1 shared publication - Sophia Elissa Altin
Department of Medicine, Section of Cardiovascular Medicine, Yale New Haven Hospital, New Haven, CT, USA.
1 shared publication
Latest Publications
- Open Access
- 14 April 2018
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 7 (4) , 82
Review of the Latest Percutaneous Devices in Critical Limb Ischemia
Critical limb ischemia (CLI) is a terminal stage of peripheral arterial disease that, in the absence of intervention, may lead to lower extremity amputation or death. Endovascular interventions have become a first-line approach to the management of CLI and have advanced considerably within the past decade. This review summarizes the types of percutaneous devices and the techniques that are available for the management of CLI and the data supporting their use. These include devices that establish and maintain vessel patency, including percutaneous transluminal angioplasty, drug-coated balloons, bare metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and atherectomy; devices that provide protection from embolization; and, cell-based therapies. Additionally, ongoing trials with important implications for the field are discussed.
- 14 April 2018
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 7 (4) , 82
Open AccessReview of the Latest Percutaneous Devices in Critical Limb Ischemia
Critical limb ischemia (CLI) is a terminal stage of peripheral arterial disease that, in the absence of intervention, may lead to lower extremity amputation or death. Endovascular interventions have become a first-line approach to the management of CLI and have advanced considerably within the past decade. This review summarizes the types of percutaneous devices and the techniques that are available for the management of CLI and the data supporting their use. These include devices that establish and maintain vessel patency, including percutaneous transluminal angioplasty, drug-coated balloons, bare metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and atherectomy; devices that provide protection from embolization; and, cell-based therapies. Additionally, ongoing trials with important implications for the field are discussed.